US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 70.570
  • +0.200+0.28%
Close Apr 26 16:00 ET
  • 70.570
  • 0.0000.00%
Post 16:13 ET
1.27BMarket Cap24.00P/E (TTM)

Ligand Pharmaceuticals Key Stats

Ligand Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 7, 2024

Revenue(YoY)

27.92M

-36.51%
EPS(YoY)

0.23

-90.27%

Strong Buy

Mar 31, 2024

Ligand Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 33.195M--
May 7, 20242024/Q1-- / 27.924M--
Feb 27, 20242023/Q428.101M / 25.645M--
Nov 8, 20232023/Q332.868M / 27.224M--
Aug 8, 20232023/Q226.366M / 25.733M--
May 4, 20232023/Q143.979M / 33.547M--
Feb 22, 20232022/Q450.382M / 39.635M--
Nov 7, 20222022/Q366.088M / 38.332M--
Aug 8, 20222022/Q257.419M / 37.735M--
May 4, 20222022/Q145.693M / 34.213M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 33.195M--
May 7, 20242024/Q1-- / 27.924M--
Feb 27, 20242023/Q428.101M / 25.645M--
Nov 8, 20232023/Q332.868M / 27.224M--
Aug 8, 20232023/Q226.366M / 25.733M--
May 4, 20232023/Q143.979M / 33.547M--
Feb 22, 20232022/Q450.382M / 39.635M--
Nov 7, 20222022/Q366.088M / 38.332M--
Aug 8, 20222022/Q257.419M / 37.735M--
May 4, 20222022/Q145.693M / 34.213M--

Unlock Free Earnings Estimates

Ligand Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg